NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • Activities during COVID-19
    • Strategic Partnership Board
    • Steering Committee
    • Promoting Equality, Diversity and Inclusion in Research
    • Current Vacancies
    • Contact Us
    • Stay in Touch
  • Research
    • Research Themes Overview
    • Cancer
    • Cardiovascular Medicine
    • Digital Health from Hospital to Home
    • Gene and Cell Therapy
    • Genomic Medicine
    • Imaging
    • Inflammation across Tissues
    • Life-saving Vaccines
    • Metabolic Experimental Medicine
    • Modernising Medical Microbiology and Big Infection Diagnostics
    • Musculoskeletal
    • Preventive Neurology
    • Respiratory Medicine
    • Surgical Innovation, Technology and Evaluation
    • Translational Data Science
  • Patient & Public Involvement
    • Getting involved with research
    • View and register for involvement opportunities
    • Patient & Public Groups
    • Patient and Public Involvement Advisory Group
    • Diversity in Research Group
    • Oxford Blood Group
    • Case Studies
    • PPIE Strategy
    • PPIE News
    • PPI Researcher Guidance
    • Researchers: Post a PPIE opportunity
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Preparatory Research Fellowships
    • Senior Research Fellowships
    • Research Training Bursaries
    • Doctoral Awards
    • Post-Doctoral Awards
    • Other funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • Who Do We Work With?
    • Events
    • Further Information and Additional Resources
    • Contacts for Industry
  • Videos
  • News
  • Events
Research Theme

Metabolic Experimental Medicine

You are here: Home > Research Themes Overview > Metabolic Experimental Medicine

Metabolic Experimental Medicine

Our overarching aim is to enhance the care of patients with, or at risk of metabolic disease such as type 1 and type 2 diabetes and non-alcoholic fatty liver disease (NAFLD).

There are almost 4 million people living with diabetes in the UK and their care consumes 10% of the NHS budget, a figure that is expected to rise in the coming years. An estimated 10 million people in the UK have NAFLD.

Using world-leading knowledge of cellular and tissue biology developed in Oxford, we will look at the pancreas (for type 1 diabetes) and liver (for type 2 diabetes and NAFLD). This will feed into our understanding of the mechanisms that might drive these diseases.

We can then combine this with small-scale experimental medicine studies to define the processes that determine how these metabolic diseases progress, and enhance the care of people living with, or at high risk of these metabolic diseases.

Based on our findings, we can trial new interventions with patients and eventually explore the possibility of them being adopted into wider clinical practice in the NHS.

Sub-themes in this theme reflect these key stages in tackling the three diseases:

  • Cellular & Molecular physiology and pathology
  • Experimental metabolic medicine and integrative physiology
  • Translating experimental medicine into state-of-the art care

Read more about our work on

Type 1 diabetes

Type 2 diabetes

Non-alcoholic fatty liver disease

Much of the work in this theme lies within the Oxford Centre for Diabetes, Endocrinology and Metabolism – a pioneering centre that combines basic and clinical research, clinical care and education. 

Researchers in this theme will work closely with colleagues in other BRC themes, notably Cancer (especially around the liver); Genetics (looking at fat cells and liver cells); and Imaging (in NAFLD clinical studies).

Our work is very much aligned with patient needs and the priorities outlined by the James Lind Alliance. We have active panels of patients living with metabolic disease and public champions in our management group.

Metabolic Experimental Medicine

  • Metabolic Experimental Medicine
  • Type 1 diabetes
  • Type 2 diabetes
  • Non-alcoholic fatty liver disease (NAFLD)
  • Oxford Biobank / BioResource
  • Clinical Research Unit / Clinical Investigation Unit
  • Patient involvement
  • Contacts
  • Videos
  • News

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Oxford BRC on Social Media

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2023 NIHR Oxford Biomedical Research Centre